ClinicalTrials.Veeva

Menu

Parameter Space of kTMP (SBIR_2022)

M

Magnetic Tides

Status

Invitation-only

Conditions

Healthy

Treatments

Device: Sham kTMP
Device: kTMP

Study type

Interventional

Funder types

Industry

Identifiers

NCT05959031
MagneticTides

Details and patient eligibility

About

The investigators have recently developed a new non-invasive brain stimulation (NIBS) system, kilohertz transcranial magnetic perturbation (kTMP) that opens up a new experimental space for safely modulating neural excitability in targeted areas of the human brain. This project will characterize the broad parameter space of kTMP in terms of tolerability and efficacy in healthy individuals. Following earlier feasibility studies, we are now increasing our number of subjects in order to capture preliminary safety and effectiveness information on a near-final device.

Full description

Non-invasive brain stimulation (NIBS) has attracted considerable interest in the cognitive neuroscience community, providing an important basic research tool to study brain function, with emerging clinical applications to enhance function in individuals with neurological disorders.

The investigators have developed a radically new NIBS approach, one in which subthreshold modulation of neural excitability is brought about via oscillating magnetic fields at kilohertz (kHZ) frequencies. This system, referred to kTMP (kHz Transcranial Magnetic Perturbation) significantly increases the range of subthreshold E-field induction, and through modulation of the envelope of the kHz carrier frequency, can impose E-fields at physiological relevant frequencies. The investigators will conduct testing with healthy human participants to assess the tolerability and efficacy of the system in producing changes in cortical physiology.

Enrollment

200 estimated patients

Sex

All

Ages

18 to 75 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Age 18-75

Exclusion criteria

  • serious medical condition
  • had a seizure of any sort
  • epilepsy or experienced seizures
  • neurological disorder
  • head injury
  • stroke
  • had any form of brain surgery
  • history of migraine
  • metal implants in your head, excluding the mouth
  • pacemaker
  • implanted medical devices of any sort
  • pregnant
  • hearing loss or hearing impairments
  • jet lag
  • stress
  • substance abuse
  • highly stressful event over the past 24 hours
  • broken or abnormal skin on your scalp

Trial design

Primary purpose

Device Feasibility

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

200 participants in 2 patient groups

active kTMP
Experimental group
Description:
Participants received 0.5 - 8 V/m of active stimulation.
Treatment:
Device: kTMP
sham kTMP
Sham Comparator group
Description:
Participants received 0.01 V/m of sham stimulation.
Treatment:
Device: Sham kTMP

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems